To explore why the effects of MUC15 on cancer progression can be diametrically opposed to those of larger glycoproteins, we hypothesized that the glycoprotein size distribution determines the effect of the glycocalyx on integrin activation and dynamics. The gene discussed is MUC15; the disease is cancer.